Cargando…

Development and validation of a deep learning-based approach to predict the Mayo endoscopic score of ulcerative colitis

BACKGROUND: The ulcerative colitis (UC) Mayo endoscopy score is a useful tool for evaluating the severity of UC in patients in clinical practice. OBJECTIVES: We aimed to develop and validate a deep learning-based approach to automatically predict the Mayo endoscopic score using UC endoscopic images....

Descripción completa

Detalles Bibliográficos
Autores principales: Qi, Jing, Ruan, Guangcong, Ping, Yi, Xiao, Zhifeng, Liu, Kaijun, Cheng, Yi, Liu, Rongbei, Zhang, Bingqiang, Zhi, Min, Chen, Junrong, Xiao, Fang, Zhao, Tingting, Li, Jiaxing, Zhang, Zhou, Zou, Yuxin, Cao, Qian, Nian, Yongjian, Wei, Yanling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10214058/
https://www.ncbi.nlm.nih.gov/pubmed/37251086
http://dx.doi.org/10.1177/17562848231170945
Descripción
Sumario:BACKGROUND: The ulcerative colitis (UC) Mayo endoscopy score is a useful tool for evaluating the severity of UC in patients in clinical practice. OBJECTIVES: We aimed to develop and validate a deep learning-based approach to automatically predict the Mayo endoscopic score using UC endoscopic images. DESIGN: A multicenter, diagnostic retrospective study. METHODS: We collected 15120 colonoscopy images of 768 UC patients from two hospitals in China and developed a deep model based on a vision transformer named the UC-former. The performance of the UC-former was compared with that of six endoscopists on the internal test set. Furthermore, multicenter validation from three hospitals was also carried out to evaluate UC-former’s generalization performance. RESULTS: On the internal test set, the areas under the curve of Mayo 0, Mayo 1, Mayo 2, and Mayo 3 achieved by the UC-former were 0.998, 0.984, 0.973, and 0.990, respectively. The accuracy (ACC) achieved by the UC-former was 90.8%, which is higher than that achieved by the best senior endoscopist. For three multicenter external validations, the ACC was 82.4%, 85.0%, and 83.6%, respectively. CONCLUSIONS: The developed UC-former could achieve high ACC, fidelity, and stability to evaluate the severity of UC, which may provide potential application in clinical practice. REGISTRATION: This clinical trial was registered at the ClinicalTrials.gov (trial registration number: NCT05336773)